Research Study Shows 'Functional Fluidics' Biomarkers Can Help Predict Sickle Cell Disease Pain Crises and Monitor Drug Therapy Progress News provided by Share this article DETROIT, Feb. 16, 2021 /PRNewswire/ -- Functional Fluidics ( https://www.functionalfluidics.com/) recently participated in a pivotal study that indicates their biomarkers of red blood cell health can help define and predict acute pain crises in individuals with Sickle Cell Disease (SCD). This addresses a tremendous need for well-validated biomarkers to objectively monitor red blood cell health in individuals with sickle cell disease. Red Blood Cell Biomarker Assays developed by Functional Fluidics showed significant correlation with patient-reported events in the recently published American Society of Hematology Blood Magazine